Senior insider sale
Executive Chairman at NOVOCURE LTD — senior position signals high conviction
$932.9K
71.89K shares
What this filing means
DOYLE WILLIAM F plans to sell 71.89K shares of NOVOCURE LTD valued at approximately $932.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/3/2026ACC: 0001950047-26-002120
DirectorOfficer· Executive Chairman
Since Mar 2026
71.89K
Shares to sell
$932.9K
Approx. market value
71.89K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Performance Shares
Not Applicable
3/3/2026
71.89KTotal acquired71.89K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/3/2026 | Performance Shares Not Applicable | 71.89K | — |
| Total | 71.89K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
71.89K
Market value
$932.9K
3/3/2026
Total
Units
71.89K
Value
$932.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/3/2026 | 71.89K | $932.9K | NASDAQ | Planned |
| Total | 71.89K | $932.9K | ||